These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18941082)

  • 41. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
    Salem S; Houseni M; Zidan L; Kandil A
    Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
    Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
    Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
    Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
    Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
    Inoue K; Sato T; Kitamura H; Ito M; Tsunoda Y; Hirayama A; Kurosawa H; Tanaka T; Fukushi M; Moriyama N; Fujii H
    Ann Nucl Med; 2008 Jan; 22(1):41-8. PubMed ID: 18250986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
    An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK
    Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.
    Coenegrachts K; De Geeter F; ter Beek L; Walgraeve N; Bipat S; Stoker J; Rigauts H
    Eur Radiol; 2009 Feb; 19(2):370-9. PubMed ID: 18795299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
    AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
    Veit-Haibach P; Treyer V; Strobel K; Soyka JD; Husmann L; Schaefer NG; Tschopp A; Hany TF
    Abdom Imaging; 2010 Oct; 35(5):528-36. PubMed ID: 19593563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
    Surasi DS; O'Malley JP; Bhambhvani P
    J Nucl Med Technol; 2015 Sep; 43(3):229-30. PubMed ID: 25655342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
    Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR
    Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?
    Strauss LG; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1902-5. PubMed ID: 17938920
    [No Abstract]   [Full Text] [Related]  

  • 52. FDG PET and Split-Bolus Multi-Detector Row CT Fusion Imaging in Oncologic Patients: Preliminary Results.
    Scialpi M; Palumbo I; Gravante S; Buresta T; D'Andrea A; Pierotti L; Palumbo B
    Radiology; 2016 Mar; 278(3):873-80. PubMed ID: 26361222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography.
    Ghanem N; Altehoefer C; Högerle S; Nitzsche E; Lohrmann C; Schäfer O; Kotter E; Langer M
    Eur J Radiol; 2005 May; 54(2):264-70. PubMed ID: 15837408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
    Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
    Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms.
    Miller FH; Butler RS; Hoff FL; Fitzgerald SW; Nemcek AA; Gore RM
    AJR Am J Roentgenol; 1998 Sep; 171(3):643-9. PubMed ID: 9725290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
    Kitajima K; Murakami K; Yamasaki E; Domeki Y; Kaji Y; Fukasawa I; Inaba N; Suganuma N; Sugimura K
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1439-48. PubMed ID: 18418592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing respiratory gated with delayed scans in the detection of colorectal carcinoma hepatic and pulmonary metastases with 18F-FDG PET-CT.
    Hassler S; Hubele F; Constantinesco A; Goetz C
    Clin Nucl Med; 2014 Jan; 39(1):e7-e13. PubMed ID: 23751828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved imaging of intrahepatic colorectal metastases with 18F-fluorodeoxyglucose respiratory-gated positron emission tomography.
    Fin L; Daouk J; Bailly P; Slama J; Morvan J; El Esper I; Régimbeau JM; Chatelain D; Diouf M; Meyer ME
    Nucl Med Commun; 2012 Jun; 33(6):656-62. PubMed ID: 22382308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CT of hypervascular hepatic tumors: are unenhanced scans necessary for diagnosis?
    Patten RM; Byun JY; Freeny PC
    AJR Am J Roentgenol; 1993 Nov; 161(5):979-84. PubMed ID: 8273641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.
    Quarles van Ufford HM; Quekel LG; van Waes PF; de Haas PJ; de Klerk JM
    Hell J Nucl Med; 2007; 10(2):105-8. PubMed ID: 17684586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.